BDE vs Exparel for Hernia Pain Relief

No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares how two different numbing medications help patients feel the least amount of pain while recovering from surgery.

Who Is on the Research Team?

BA

Bola Aladegbami, MD

Principal Investigator

Baylor Scott and White Health

Are You a Good Fit for This Trial?

Inclusion Criteria

I am having abdominal wall surgery and will get a TAP block.
I am 18 years old or older.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either BDE or Exparel before abdominal wall reconstruction surgery

Surgery Day
1 visit (in-person)

Post-Operative Monitoring

Participants are monitored for pain control and medication usage using the PNRS questionnaire

4 days
Daily monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment, including pain control and medication usage

2 weeks
1 visit (in-person)

Extended Follow-up

Participants are assessed for hospital stay duration, bowel function, and total cost

30-45 days after hospital discharge

What Are the Treatments Tested in This Trial?

Interventions

  • BDE
  • Exparel

How Is the Trial Designed?

2

Treatment groups

Active Control

Group I: BDE for hernia patientsActive Control1 Intervention
Group II: Exparel for hernia patientsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+